no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles
|
Shaila, Melkote S. |
|
2007 |
25 |
18 |
p. 3567-3573 7 p. |
article |
2 |
Editorial Board
|
|
|
2007 |
25 |
18 |
p. CO2- 1 p. |
article |
3 |
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy
|
Kasperska-Zajac, Alicja |
|
2007 |
25 |
18 |
p. 3595-3598 4 p. |
article |
4 |
Enhanced decision support for policy makers using a web interface to health-economic models—Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands
|
Hubben, G.A.A. |
|
2007 |
25 |
18 |
p. 3669-3678 10 p. |
article |
5 |
Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)
|
Kęsik, Małgorzata |
|
2007 |
25 |
18 |
p. 3619-3628 10 p. |
article |
6 |
Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine
|
Dennehy, Maureen |
|
2007 |
25 |
18 |
p. 3646-3657 12 p. |
article |
7 |
Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin
|
Lagergård, Teresa |
|
2007 |
25 |
18 |
p. 3606-3614 9 p. |
article |
8 |
Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine
|
Devlin, Joanne M. |
|
2007 |
25 |
18 |
p. 3561-3566 6 p. |
article |
9 |
Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo
|
Khan, Mohammad A.H. |
|
2007 |
25 |
18 |
p. 3544-3553 10 p. |
article |
10 |
Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations
|
Pinitkiatisakul, Sunan |
|
2007 |
25 |
18 |
p. 3658-3668 11 p. |
article |
11 |
Impact of hepatitis A vaccination on health care utilization in the United States, 1996–2004
|
Zhou, Fangjun |
|
2007 |
25 |
18 |
p. 3581-3587 7 p. |
article |
12 |
Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model
|
Ninomiya, Ai |
|
2007 |
25 |
18 |
p. 3554-3560 7 p. |
article |
13 |
Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis
|
Kajikawa, Akinobu |
|
2007 |
25 |
18 |
p. 3599-3605 7 p. |
article |
14 |
Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection
|
Mallick, A.I. |
|
2007 |
25 |
18 |
p. 3692-3704 13 p. |
article |
15 |
Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules
|
Wilson, Jamie N. |
|
2007 |
25 |
18 |
p. 3705-3712 8 p. |
article |
16 |
Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine
|
Grunow, Roland |
|
2007 |
25 |
18 |
p. 3679-3683 5 p. |
article |
17 |
Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls
|
Moorthy, G. |
|
2007 |
25 |
18 |
p. 3636-3645 10 p. |
article |
18 |
Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine
|
Fittipaldi, Nahuel |
|
2007 |
25 |
18 |
p. 3524-3535 12 p. |
article |
19 |
Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine
|
Zeng, Mingtao |
|
2007 |
25 |
18 |
p. 3588-3594 7 p. |
article |
20 |
Seroprevalence of rubella among Jordanian women of childbearing age
|
Jarour, Najwa |
|
2007 |
25 |
18 |
p. 3615-3618 4 p. |
article |
21 |
Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials
|
Mehrishi, Jitendra N. |
|
2007 |
25 |
18 |
p. 3517-3523 7 p. |
article |
22 |
Sustained measles elimination in Australia and priorities for long term maintenance
|
Gidding, Heather F. |
|
2007 |
25 |
18 |
p. 3574-3580 7 p. |
article |
23 |
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys
|
Rojas Caraballo, Jose |
|
2007 |
25 |
18 |
p. 3713-3721 9 p. |
article |
24 |
The PGRS domain of Mycobacterium tuberculosis
|
Campuzano, Jaime |
|
2007 |
25 |
18 |
p. 3722-3729 8 p. |
article |
25 |
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge study
|
McKenzie, Robin |
|
2007 |
25 |
18 |
p. 3684-3691 8 p. |
article |
26 |
Vaccination of horses against strangles using recombinant antigens from Streptococcus equi
|
Waller, Andrew |
|
2007 |
25 |
18 |
p. 3629-3635 7 p. |
article |
27 |
Vaccine safety perceptions and experience with adverse events following immunization in Kazakhstan and Uzbekistan: A summary of key informant interviews and focus groups
|
Fowler, Gabrielle L. |
|
2007 |
25 |
18 |
p. 3536-3543 8 p. |
article |